It is over 7 months since the FDA denied the Provenge Biologics License Application for Prostate Cancer. Last week John Fish, suffering from late stage prostate cancer, was admitted to a hospice without ever having been given the opportunity to receive this immunotherapy to try to strengthen his body to fight for his life. John has however, joined with CareToLive and hopefully although it may be too late for him, he and his wife Marlilyn have courageously stood toe to toe with us, along with many of our other members with prostate cancer, to try to make this treatment available for the rest of the 30,000 men who will surely die this year without it.

Finally! Thanks to the efforts of CareToLive, a non profit, led by attorney Kerry Donahue, and Scott Riccio of ARightToLive, and the many, many members and supporters of CareToLive and Provenge, an immunotherapy voted overwhelmingly safe and effective by an FDA panel of experts to approve this treatment for prostate cancer, and then denied without adequate explanation by the FDA, three of our congressmen, Mike Michaud of Maine, Dan Burton of Indiana, and Tim Ryan of Ohio are asking for a congressional hearing into what happened. We must continue to be vigilant and to contact our representatives in the Congress to keep the pressure on, and to demand a congressional hearing.

CONGRESSIONAL LETTER ASKING FOR A HEARING  PDF (click here) Please fax this letter to your own congressional representatives and ask them to join this action. TIA

An Easy Way To Contact Your Elected Officials - (click here) EVERY VOICE COUNTS!

This is a grassroots movement. We need EVERYBODY’S help. See you at the hearings!

Please visit our website and read our blogs to learn about the 3 “leaked” letters and so much more, Continue Reading The FDA Said NO, CareToLive & ARightToLive say GO FISH! »

Popularity: 41%

While Michael Milken and the Prostate Cancer Foundation are whooping it up at the ballgame, some men are sneaking off to have their testicles removed in hopes that it will stop their PSA from rising, and their lives from ending prematurely from late stage prostate cancer. 1 in 6 men will be diagnosed with prostate cancer in their lifetimes. Over 30,000 American men will die from prostate cancer this year. Only 1 very toxic drug has been approved for late stage pc in over 42 years.

Along came Dendreon’s Provenge, an Immunotherapy voted overwhelmingly safe and effective by the FDA’s panel of experts convened to review Provenge. Was there foul play afoot when the FDA decided to delay approval. Perhaps if our men put some extra pine tar on their bats, we could get some coverage of this story. You would think that the deaths of 15,000 men since the delay would be enough.

Note the Picture on the bottom — David Solit, Tommy Lasorda, Dr. Howard Soule, Dr. Howard Scher and Mike Milken join together in support of the PCF’s Home Run Challenge at the New York Mets vs. Anaheim Angels game on June 10th, 2005 (click link)

Why hasn’t Michael Milken and his Prostate Cancer Foundation stepped up to the plate and publicly voiced his disappointment and disapproval of the decision by the FDA to delay Provenge? Is Milken financially conflicted? The whole thing is permeating a stench in the world of financially conflicted advocacy groups. Continue Reading Michael Milken and the Prostate Cancer Foundation’s Foul Balls »

Popularity: 98%

Download the leaked letters - Click here

This is the continuing saga of the Provenge debacle whereby men with terminal prostate cancer are being denied access to Provenge, a safe and effective immunotherapy. Has the Chemo Cartel tossed off this immunotherapy to the detriment of the men who are desperately seeking access in order to keep the the profits rolling in? Stay tuned as we try to get to the bottom of this. Please leave your comments be sure to Digg this post. TIA

Popularity: 75%